At a glance
- Originator Ferrer
- Class Antidepressants
- Mechanism of Action Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Clinical Phase Unknown Major depressive disorder
Most Recent Events
- 31 Aug 2006 Preclinical trials in Depression in Spain (unspecified route)